-
Phase II study of Capecitabine and Cisplatin for patients with metastatic Hepatocellular carcinoma
-
., , , , , , , , , ,
-
Korean J Med. 2007;73(1):146-146.
-
-
PDF
-
Irinotecan combined with infusional 5-FU and leucovorin for the treatment of metastatic or recurrent gastric cancer as the second-line chemotherapy.
-
., , , , , , , , , , ,
-
Korean J Med. 2007;73(1):146-146.
-
-
PDF
-
Expression of excision repair cross-complementation group 1 protein predicts poor outcome in patients with small cell lung cancer
-
., , , , , , , , , , ,
-
Korean J Med. 2007;73(1):149-149.
-
-
PDF
-
국소 진행 비인두암 환자에서 Cisplatin 투여스케줄에 따른 항암제-방사선 동시치료법의 치료결과분석
-
., , , , , , , , , , , ,
-
Korean J Med. 2007;73(1):151-151.
-
-
PDF
-
Phase II Study of chemotherapy with gemcitabine and cisplatin followed by chemoradiotherapy with capecitabine for locally advanced pancreatic cancer
-
., , , , , , , , , , , ,
-
Korean J Med. 2007;73(1):152-152.
-
-
PDF
-
Clinical outcomes of metastatic breast cancer patients with triple-negative phenotype who received platinum-containing chemotherapy
-
., , , , , , , , , , , ,
-
Korean J Med. 2007;73(1):153-153.
-
-
PDF
-
Nongastric marginal zone B-cell lymphoma : A prognostic model from a retrospective multicenter study.
-
., , , , , , , , , , , , , , , , , ,
-
Korean J Med. 2007;73(1):157-157.
-
-
PDF
-
MTHFR polymorphisms of both donor and recipient can modify recurrence rate in allogeneic hematopoietic stem cell transplantation.
-
., , , , , , , , , ,
-
Korean J Med. 2007;73(1):157-157.
-
-
PDF
|